Actual Medicinal Product (AMP) Oxybutynin 2.5mg tablets (Approved Prescription Services Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Light sensitive medicine. Store in light resistant container. Moisture sensitive medicine. Store in airtight (sealed) MCA. Stability study supports up to 4 weeks in a sealed MCA. Manufacturer recommends storing in original container.
- Provenance
-
This recommendation is based on the products Ditropan 2.5mg tablets (Neon Healthcare Ltd) and Oxybutynin 5mg tablets (Tillomed Laboratories Ltd).
- Generic
- Oxybutynin
- Formulation
- Oxybutynin 2.5mg tablets
-
Oxybutynin
-
Oxybutynin 2.5mg tablets
-
Oxybutynin 2.5mg tablets (Approved Prescription Services Ltd)
-
-
Oxybutynin 3mg tablets